Welcome!
The CASNMMI annual meeting took place at Marriott Marquis Chicago on June 25, 2023 during the SNMMI 2023 Annual Meeting (June 24-27, 2023 | Chicago, IL, USA).
Lifetime Achievement Awards (LTAA)
Professor Wei-Jen Shih (施維貞教授)
Dr. Shih received his medical degree from National Defense Medical Center Taiwan, trained as a nuclear medicine specialist using advanced imaging techniques to diagnose diseases and monitor therapies, and had been serving as a full-time faculty member in practice for more than 40 years at the University of Kentucky Medical Center. He was the recipient of the Fulbright scholar from University of Bonn, Germany, in 1989. Starting the early 1990s, Dr. Shih promoted research collaborations and exchanges between United States and China, attended and contributed to the successful conferences took place in China: The second Sino-American Nuclear Medicine Conference in August 18-20, 1991, Beijing, China. The First World Chinese Conference of Nuclear Medicine in August 8-11, 1993, Wuxi, Jiangsu Province, China. Dr. Shih was the 9th President of CASNM 1993 - 1995. His research over more than 40 years have resulted in over 450 peer-reviewed journal articles. Congratulations to Dr.Wei-Jen Shih receiving 2023 CASNMMI Lifetime Achievement Award in Chicago.
Congratulations to all Young Investigator Award (YIA) winners!
1st Prize: Xuedan Wu, University of North Carolina at Chapel Hill, USA.
Efficient 11C-Cyanation of Electron-Rich Arenes via Organic Photoredox Catalysis
2nd Prize: Kevin Cheng, University of Michigan, USA.
Development of Next-Generation Methodologies for Copper-Mediated Radical [11C]Cyanation of Aryl Electrophiles.
2nd Prize: Qiong Liu, Yale University, USA.
Dynamic Imaging and Tracer Kinetic Modeling of 18F flutemetamol PET for Cardiac Amyloidosis Patients
3rd Prize: Lu Wang, Sun Yat-sen University, China.
Molecular Imaging of Sphingosine-1-phosphate Receptor 1 via PET Tracer [18F]-TZ4877 in Response to Electro-puncture Treatment for Alzheimer's disease.
3rd Prize: Vivianne Jakobsson, National University of Singapore, Singapore.
First-in-human study of a novel radiolabeled fibroblast activating protein (FAP)-targeted peptide 68Ga-FAP-3BP-3940 for PET/CT imaging in patients with solid tumors.
3rd Prize: Ruiqi Liu, Chinese Academy of Sciences, China.
Dual-wavelength Comparative Imaging Based on a Novel NIR-II/IIb Emissive Rare Earth-Doped Nanoparticle.